Keyphrases
Transplantation
100%
Allogeneic
100%
Myeloproliferative Neoplasms
100%
Tyrosine Kinase Inhibitor
100%
Hematopoietic Progenitor Cell Transplantation
100%
Myelofibrosis
50%
Treatment Modalities
25%
Improved Efficacy
25%
Number of Patients
25%
Advanced Disease
25%
Increased Safety
25%
Drug Therapy
25%
Chronic Myeloid Leukemia
25%
Allogeneic Transplantation
25%
Advanced Phase
25%
Treatment-related Mortality
25%
Reduced-intensity Conditioning
25%
Spleen Size
25%
Alternative Donor
25%
Janus Kinase Inhibitors
25%
Delayed Transplantation
25%
Mainstream Treatment
25%
Medicine and Dentistry
Hematopoietic Cell
100%
Tyrosine-Kinase Inhibitor
100%
Cell Transplantation
100%
Myeloproliferative Neoplasm
100%
Diseases
100%
Myelofibrosis
50%
Drug Therapy
25%
Allograft
25%
Reduced Intensity Conditioning
25%
Janus Kinase 2 Inhibitor
25%
Chronic Myelomonocytic Leukemia
25%
Alternative Donor
25%
Chronic Myelogenous Leukemia
25%